New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Consuming your own fecal microbiome when dieting may limit weight regain

Consuming your own fecal microbiome when dieting may limit weight regain

by American Associates, Ben-Gurion University of the NegevIn the weight loss trial, abdominally obese or dyslipidemic (high cholesterol) participants in Israel were randomly assigned to one of th
Gastroenterology June 08,2024
Consuming your own fecal microbiome when dieting may limit weight regain

Consuming your own fecal microbiome when dieting may limit weight regain

by American Associates, Ben-Gurion University of the NegevIn the weight loss trial, abdominally obese or dyslipidemic (high cholesterol) participants in Israel were randomly assigned to one of th
Gastroenterology June 08,2024
Capsule delivery of fecal microbiota transplant has similar effectiveness to transplant by colonoscopy

Capsule delivery of fecal microbiota transplant has similar effectiveness to transplant by colonoscopy

by University of Minnesota Medical SchoolFMT Capsules for Oral Delivery. Credit: University of Minnesota Microbiota Therapeutics ProgramRecent work published inClinical Gastroenterology and
Gastroenterology June 08,2024
Capsule delivery of fecal microbiota transplant has similar effectiveness to transplant by colonoscopy

Capsule delivery of fecal microbiota transplant has similar effectiveness to transplant by colonoscopy

by University of Minnesota Medical SchoolFMT Capsules for Oral Delivery. Credit: University of Minnesota Microbiota Therapeutics ProgramRecent work published inClinical Gastroenterology and
Gastroenterology June 08,2024
Researchers take aim at circadian clock in deadly brain cancer

Researchers take aim at circadian clock in deadly brain cancer

by University of Southern CaliforniaA microscope image of brain cancer cells, a glioma tumor type known as anaplastic astrocytoma. Credit: Wikimedia/ CC BY-SA 3.0Scientists at USC and UC San Dieg
Oncology June 08,2024
Researchers take aim at circadian clock in deadly brain cancer

Researchers take aim at circadian clock in deadly brain cancer

by University of Southern CaliforniaA microscope image of brain cancer cells, a glioma tumor type known as anaplastic astrocytoma. Credit: Wikimedia/ CC BY-SA 3.0Scientists at USC and UC San Dieg
Oncology June 08,2024
Researchers criticize study calling for expansion of genetic testing for breast cancer

Researchers criticize study calling for expansion of genetic testing for breast cancer

by University of CambridgeMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaResearchers at the Unive
Oncology June 08,2024
Researchers criticize study calling for expansion of genetic testing for breast cancer

Researchers criticize study calling for expansion of genetic testing for breast cancer

by University of CambridgeMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaResearchers at the Unive
Oncology June 08,2024
Researchers may have discovered why some tumors grow back aggressively after radiation, chemotherapy

Researchers may have discovered why some tumors grow back aggressively after radiation, chemotherapy

by Laura Castañón,Northeastern UniversityPhoto: Rifat Sipahi, left, and Gunther Zupanc work in a lab in the Mugar Life Sciences Building. Credit: Adam Glanzman/Northeastern UniversityMany of the
Oncology June 08,2024
Researchers may have discovered why some tumors grow back aggressively after radiation, chemotherapy

Researchers may have discovered why some tumors grow back aggressively after radiation, chemotherapy

by Laura Castañón,Northeastern UniversityPhoto: Rifat Sipahi, left, and Gunther Zupanc work in a lab in the Mugar Life Sciences Building. Credit: Adam Glanzman/Northeastern UniversityMany of the
Oncology June 08,2024
Researchers determine epigenetic origin of docetaxel-resistant breast cancer

Researchers determine epigenetic origin of docetaxel-resistant breast cancer

by IDIBELL-Bellvitge Biomedical Research InstituteResearchers at the Bellvitge Biomedical Research Institute (IDIBELL), published today in Molecular Cancer Research a study where they identify me
Oncology June 08,2024
Researchers determine epigenetic origin of docetaxel-resistant breast cancer

Researchers determine epigenetic origin of docetaxel-resistant breast cancer

by IDIBELL-Bellvitge Biomedical Research InstituteResearchers at the Bellvitge Biomedical Research Institute (IDIBELL), published today in Molecular Cancer Research a study where they identify me
Oncology June 08,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com